100 related articles for article (PubMed ID: 9923089)
1. Meal-related changes in plasma CCK bioactivity in patients with chronic pancreatitis.
Nakamura T; Tando Y; Yamada N; Imamura K; Ishii M; Terada A; Takebe K; Kaji A; Watanabe T; Suda T; Koide M; Otsuki M
Acta Gastroenterol Belg; 1998; 61(4):400-6. PubMed ID: 9923089
[TBL] [Abstract][Full Text] [Related]
2. [Plasma cholecystokinin level in chronic pancreatitis].
Mössner J; Back T; Regner U; Fischbach W
Z Gastroenterol; 1989 Aug; 27(8):401-5. PubMed ID: 2609704
[TBL] [Abstract][Full Text] [Related]
3. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
[TBL] [Abstract][Full Text] [Related]
4. Plasma cholecystokinin levels in patients with chronic pancreatitis.
Schafmayer A; Becker HD; Werner M; Fölsch UR; Creutzfeldt W
Digestion; 1985; 32(2):136-9. PubMed ID: 4043564
[TBL] [Abstract][Full Text] [Related]
5. Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation.
Slaff JI; Wolfe MM; Toskes PP
J Lab Clin Med; 1985 Mar; 105(3):282-5. PubMed ID: 3973464
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of neurotensin and CCK in patients with chronic pancreatitis with and without enzyme substitution.
Nustede R; Köhler H; Fölsch UR; Schafmayer A
Pancreas; 1991 May; 6(3):260-5. PubMed ID: 1713670
[TBL] [Abstract][Full Text] [Related]
7. Oral glucose ingestion stimulates cholecystokinin release in normal subjects and patients with non-insulin-dependent diabetes mellitus.
Hasegawa H; Shirohara H; Okabayashi Y; Nakamura T; Fujii M; Koide M; Otsuki M
Metabolism; 1996 Feb; 45(2):196-202. PubMed ID: 8596489
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin secretion in patients with chronic pancreatitis and after different types of pancreatic surgery.
Eddes EH; Masclee AA; Gielkens HA; Verkijk M; Vecht J; Biemond I; Lamers CB
Pancreas; 1999 Aug; 19(2):119-25. PubMed ID: 10438157
[TBL] [Abstract][Full Text] [Related]
9. Effect of pancreatic enzyme supplementation on postprandial plasma cholecystokinin secretion in patients with pancreatic insufficiency.
Jansen JB; Jebbink MC; Mulders HJ; Lamers CB
Regul Pept; 1989; 25(3):333-42. PubMed ID: 2772268
[TBL] [Abstract][Full Text] [Related]
10. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
[TBL] [Abstract][Full Text] [Related]
11. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR
Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514
[TBL] [Abstract][Full Text] [Related]
12. High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain.
Funakoshi A; Nakano I; Shinozaki H; Tateishi K; Hamaoka T; Ibayashi H
Am J Gastroenterol; 1986 Dec; 81(12):1174-8. PubMed ID: 3538853
[TBL] [Abstract][Full Text] [Related]
13. Plasma cholecystokinin concentrations in patients with advanced chronic pancreatitis.
Cantor P; Petronijevic L; Worning H
Pancreas; 1986; 1(6):488-93. PubMed ID: 3562443
[TBL] [Abstract][Full Text] [Related]
14. No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.
Nakamura T; Takebe K; Kudoh K; Ishii M; Imamura K; Kikuchi H; Kasai F; Tandoh Y; Yamada N; Arai Y
Int J Pancreatol; 1995 Feb; 17(1):29-35. PubMed ID: 8568332
[TBL] [Abstract][Full Text] [Related]
15. [Plasma cholecystokinin concentration in patients with chronic pancreatitis measured by bioassay].
Koide M; Okabayashi Y; Hasegawa H; Tani S; Fujisawa T; Nakamura T; Fujii M; Otsuki M
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2419-24. PubMed ID: 2480463
[TBL] [Abstract][Full Text] [Related]
16. Plasma CCK levels in patients with pancreatic insufficiency.
Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
[TBL] [Abstract][Full Text] [Related]
17. [Bioassay for plasma cholecystokinin bioactivity].
Sun G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):417-21. PubMed ID: 1724414
[TBL] [Abstract][Full Text] [Related]
18. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal.
Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F
Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin in acute alcoholic and biliary pancreatitis.
Räty S; Sand J; Kemppainen E; Laine S; Nordback I
Int J Pancreatol; 2000 Aug; 28(1):51-7. PubMed ID: 11185710
[TBL] [Abstract][Full Text] [Related]
20. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
Chowdhury P; Rayford PL
Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
